Triple
T22693377
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | RNA polymerase II |
E561106
|
entity |
| Predicate | hasPart |
P35
|
FINISHED |
| Object | Rpb7 subunit |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rpb7 subunit | Statement: [RNA polymerase II, hasPart, Rpb7 subunit]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Rpb7 subunit Context triple: [RNA polymerase II, hasPart, Rpb7 subunit]
-
A.
RNA polymerase II
RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
-
B.
HCV NS5B RNA-dependent RNA polymerase
HCV NS5B RNA-dependent RNA polymerase is the viral enzyme in hepatitis C virus responsible for replicating its RNA genome and a key target for direct-acting antiviral drugs.
-
C.
P-body
P-body is one of the two cooperative testing robots in the video game Portal 2, known for its tall, slender design and role in the game's co-op puzzle mode alongside Atlas.
-
D.
P-body
The P-body was General Motors' compact mid-engine car platform developed specifically for the Pontiac Fiero in the 1980s.
-
E.
Cdh1
Cdh1 is a regulatory protein that activates the anaphase-promoting complex/cyclosome (APC/C) to control mitotic exit and G1 phase progression in the cell cycle.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Rpb7 subunit Target entity description: The Rpb7 subunit is a conserved protein component of eukaryotic RNA polymerase II that forms a subcomplex with Rpb4 and plays key roles in transcription initiation, elongation, and mRNA processing.
-
A.
fibrillarin
Fibrillarin is a highly conserved nucleolar protein that functions as a core component of small nucleolar ribonucleoproteins (snoRNPs), playing a key role in rRNA processing and ribosome biogenesis.
-
B.
RNA polymerase II
RNA polymerase II is the eukaryotic enzyme complex responsible for transcribing DNA into messenger RNA and many non-coding RNAs, playing a central role in gene expression.
-
C.
HCV NS5B RNA-dependent RNA polymerase
HCV NS5B RNA-dependent RNA polymerase is the viral enzyme in hepatitis C virus responsible for replicating its RNA genome and a key target for direct-acting antiviral drugs.
-
D.
P-body
P-body is one of the two cooperative testing robots in the video game Portal 2, known for its tall, slender design and role in the game's co-op puzzle mode alongside Atlas.
-
E.
P-body
The P-body was General Motors' compact mid-engine car platform developed specifically for the Pontiac Fiero in the 1980s.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789c6ae481908975b7d27e7624ac |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.